Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
67 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

RDHL — RedHill Biopharma Ltd. Dilution Risk Tracker

Track RDHL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RDHL — Get alerts when the score changes →

As of August 28, 2026, RedHill Biopharma Ltd. (RDHL) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. RedHill Biopharma Ltd. has a market capitalization of $5.19M, 50.92B shares outstanding, 17 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 30%
🔄 Reverse Split model est. 55%
• 50-day avg $0.92 below $1 exchange minimum
📉 Score Deterioration model 10%
• Score in HIGH risk zone (67/100)
🔔 Track RDHL — Get forecast alerts →

Market Data

Market Cap$5.19M
Shares Outstanding50.92B
FloatN/A
Cash$3.97M
Debt$1.07M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 3.8% shares (2026Q1 vs prior)
17 institutional holders · 518.7K shares
#1 Yorkville Advisors Global, LP 350.9K shares
#2 GAGNON SECURITIES LLC 88.4K shares
#3 CITADEL ADVISORS LLC 20.7K shares
+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest29.9K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-04-22
3 FORM3 2026-03-19
3 FORM3 2026-03-18
3 FORM3 2026-03-18
3 FORM3 2026-03-18
Full SEC filing analysis available with free account

Recent News

No recent news

Factual RDHL Dilution Snapshot

RedHill Biopharma Ltd. (RDHL) has a DilutionScore of 67/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track RDHL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RDHL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note